AspenBio Pharma, Inc. (APPY.OB) Appoints Industry-Veteran Steve Lundy CEO, Plans to Commercialize Acute Appendicitis Blood Test
AspenBio Pharma, Inc., developer of innovative diagnostic and therapeutic products announced recently that Steve Lundy has joined the company, taking up the CEO position and becoming a member of the Company’s Board of Directors (BoD). Aspen’s innovative diagnostic and therapeutic products, for which vast un-served/under-served markets exist, are exemplified by the Company’s leading candidate, AppyScore™, for acute appendicitis blood testing, which satisfies a long-standing need of hospital emergency departments. Consequent to organizational plans and ongoing succession begun in the second half of 09, this appointment and the stepping down of Daryl Faulkner (who served as Interim CEO in 09 and…